Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1992 Oct 1;147(7):1023–1026.

Adverse events after hepatitis B vaccination.

P Duclos 1
PMCID: PMC1336290  PMID: 1393898

Full text

PDF
1023

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biron P., Montpetit P., Infante-Rivard C., Léry L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med. 1988 Dec;148(12):2685–2685. [PubMed] [Google Scholar]
  2. Cosnes A., Flechet M. L., Revuz J. Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis. 1990 Aug;23(2):65–67. doi: 10.1111/j.1600-0536.1990.tb03224.x. [DOI] [PubMed] [Google Scholar]
  3. Cottone J. A. Recent developments in hepatitis: new virus, vaccine, and dosage recommendations. J Am Dent Assoc. 1990 May;120(5):501–508. doi: 10.14219/jada.archive.1990.0068. [DOI] [PubMed] [Google Scholar]
  4. Dahl-Hansen E., Siebke J. C., Frøland S. S., Degré M. Immunogenicity of yeast-derived hepatitis B vaccine from two different producers. Epidemiol Infect. 1990 Feb;104(1):143–149. doi: 10.1017/s0950268800054625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delage G., Rémy-Prince S., Ducic S., Pierri E., Montplaisir S. Combined passive-active immunization against the hepatitis B virus of 132 newborns of chronic carrier mothers: long term results. Pediatr Infect Dis J. 1988 Nov;7(11):769–776. doi: 10.1097/00006454-198811000-00005. [DOI] [PubMed] [Google Scholar]
  6. Feldshon S. D., Sampliner R. E. Reaction to hepatitis B virus vaccine. Ann Intern Med. 1984 Jan;100(1):156–157. doi: 10.7326/0003-4819-100-1-156_2. [DOI] [PubMed] [Google Scholar]
  7. Hammond G. W., Parker J., Mimms L., Tate R., Sekla L., Minuk G. Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines. Vaccine. 1991 Feb;9(2):97–100. doi: 10.1016/0264-410x(91)90263-6. [DOI] [PubMed] [Google Scholar]
  8. Herroelen L., de Keyser J., Ebinger G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991 Nov 9;338(8776):1174–1175. doi: 10.1016/0140-6736(91)92034-y. [DOI] [PubMed] [Google Scholar]
  9. Heyward W. L., Bender T. R., McMahon B. J., Hall D. B., Francis D. P., Lanier A. P., Alward W. L., Ahtone J. L., Murphy B. L., Maynard J. E. The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions. Am J Epidemiol. 1985 Jun;121(6):914–923. doi: 10.1093/oxfordjournals.aje.a114061. [DOI] [PubMed] [Google Scholar]
  10. Kirkland L. R. Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine? South Med J. 1990 May;83(5):497–499. doi: 10.1097/00007611-199005000-00005. [DOI] [PubMed] [Google Scholar]
  11. Leonardi S., Leggio T., Barone P., Sciacca A., Musumeci S. Immune response of subjects at high risk of hepatitis B to a new genetically engineered hepatitis B vaccine administered in low doses by the intradermal route. Acta Paediatr Jpn. 1990 Aug;32(4):361–364. doi: 10.1111/j.1442-200x.1990.tb00844.x. [DOI] [PubMed] [Google Scholar]
  12. Morris C. A., Oliver P. R., Reynolds F., Selkon J. B. Intradermal hepatitis B immunization with yeast-derived vaccine: serological response by sex and age. Epidemiol Infect. 1989 Oct;103(2):387–394. doi: 10.1017/s0950268800030740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Noel I., Galloway A., Ive F. A. Hypersensitivity to thiomersal in hepatitis B vaccine. Lancet. 1991 Sep 14;338(8768):705–705. doi: 10.1016/0140-6736(91)91289-7. [DOI] [PubMed] [Google Scholar]
  14. Phanuphak P., Phanpanich T., Wongurai S., Sirivichayakul S., Sriwanthana B., Panmuong W., Utaisen O., Chutivongse S. Comparative immunogenicity study of four plasma-derived hepatitis B vaccines in Thai young adults. Vaccine. 1989 Jun;7(3):253–256. doi: 10.1016/0264-410x(89)90239-9. [DOI] [PubMed] [Google Scholar]
  15. Polakoff S., Vandervelde E. M. Immunisation of neonates at high risk of hepatitis B in England and Wales: national surveillance. BMJ. 1988 Jul 23;297(6643):249–253. doi: 10.1136/bmj.297.6643.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ribera E. F., Dutka A. J. Polyneuropathy associated with administration of hepatitis B vaccine. N Engl J Med. 1983 Sep 8;309(10):614–615. doi: 10.1056/NEJM198309083091016. [DOI] [PubMed] [Google Scholar]
  17. Rietschel R. L., Adams R. M. Reactions to thimerosal in hepatitis B vaccines. Dermatol Clin. 1990 Jan;8(1):161–164. [PubMed] [Google Scholar]
  18. Shaw F. E., Jr, Graham D. J., Guess H. A., Milstien J. B., Johnson J. M., Schatz G. C., Hadler S. C., Kuritsky J. N., Hiner E. E., Bregman D. J. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol. 1988 Feb;127(2):337–352. doi: 10.1093/oxfordjournals.aje.a114808. [DOI] [PubMed] [Google Scholar]
  19. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  20. Yang D. M., Fairweather N., Button L. L., McMaster W. R., Kahl L. P., Liew F. Y. Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol. 1990 Oct 1;145(7):2281–2285. [PubMed] [Google Scholar]
  21. Yeoh E. K., Lai C. L., Chang W. K., Lo H. Y. Comparison of the immunogenicity, efficacy and safety of 10 micrograms and 20 micrograms of a hepatitis B vaccine: a prospective randomized trial. J Hyg (Lond) 1986 Jun;96(3):491–499. doi: 10.1017/s0022172400066298. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES